Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection.
BACKGROUND
Fecal microbiota transplantation (FMT) is a safe and effective, yet infrequently used therapy for recurrent Clostridium difficile infection (CDI).


OBJECTIVE
To characterize barriers to FMT adoption by surveying physicians about their experiences and attitudes toward the use of FMT.


METHODS
An electronic survey was distributed to physicians to assess their experience with CDI and attitudes toward FMT.


RESULTS
A total of 139 surveys were sent and 135 were completed, yielding a response rate of 97%. Twenty-five (20%) physicians had treated a patient with FMT, 10 (8%) offered to treat with FMT, nine (7%) referred a patient to receive FMT, and 83 (65%) had neither offered nor referred a patient for FMT. Physicians who had experience with FMT (performed, offered or referred) were more likely to be male, an infectious diseases specialist, >40 years of age, fellowship trained and practicing in an urban setting. The most common reasons for not offering or referring a patient for FMT were: not having 'the right clinical situation' (33%); the belief that patients would find it too unappealing (24%); and institutional or logistical barriers (23%). Only 8% of physicians predicted that the majority of patients would opt for FMT if given the option. Physicians predicted that patients would find all aspects of the FMT process more unappealing than they would as providers.


CONCLUSIONS
Physicians have limited experience with FMT despite having treated patients with multiple recurrent CDIs. There is a clear discordance between physician beliefs about FMT and patient willingness to accept FMT as a treatment for recurrent CDI.
Jonathan Samuel
JS
Zipursky
Tivon I
TI
Sidorsky
Carolyn A
CA
Freedman
Misha N
MN
Sidorsky
Kathryn B
KB
Kirkland
D000328:Adult; D000368:Aged; D001691:Biological Therapy / Q000706:statistics & numerical data*; D016360:Clostridioides difficile / Q000302:isolation & purification*; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009513:New Hampshire; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D013781:Texas